In Vivo Activity of Evernimicin (SCH 27899) against Methicillin-Resistant Staphylococcus aureus in Experimental Infective Endocarditis

Currently, there exist few satisfactory alternatives to vancomycin for therapy of serious methicillin-resistant Staphylococcus aureus (MRSA) infections. We employed a rat model of aortic valve endocarditis to assess the potential efficacy of evernimicin (SCH 27899) compared with vancomycin against i...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Boucher, Helen W., Thauvin-Eliopoulos, Claudie, Loebenberg, David, Eliopoulos, George M.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90262/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11120967/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.1.208-211.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!